Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Comment by ValueRideron Mar 31, 2022 5:20pm
181 Views
Post# 34564727

RE:RE:RE:RE:Breakout investor video - MGT discussion update.....link be

RE:RE:RE:RE:Breakout investor video - MGT discussion update.....link be

if they raise capital in order to make a profitable acquisition with favourable terms, it is a mute point. One washes the other out. I'll gladly accept a capital raise under these conditions.


Hoover69 wrote: Thx B2B. Agree 100% re the uncertainty comment. I still think odds would be 65% to increase LOC versus 35% issue shares. Anybody else have thoughts on this?  Thx.
 

besttobe wrote: Hoover wrote " Do you agree re the comments made about the share capital raise and the need to stop talking about it if they do not plan to do?  "

Simple math tells me they will need to do a cash raise in order to meet their year end target. Thus either early 2023 or late 2022 they will have to do a money raise depending on whether they meet their guidance or not. IE last LOI not closed.

The money raise will either be by share issue or increasing the line of credit. I am leaning that they will more likely do a share raise than increase the line of credit, for reasons previously mentioned, MGT also mentioned possible raise and also that they have a " soft " bank agreement that did not sound binding nor favorable. The company does not have enough inventory/AR  collateral nor enough FCF to support 100mil  LOC on favorable terms. IMO

In other words it is in doubt whether they will do a share raise or not, which the market doesn't like uncertainty. 

All just my opinion of course. We shall see. 

Goodluck to you...




<< Previous
Bullboard Posts
Next >>